首页> 美国卫生研究院文献>other >Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line
【2h】

Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line

机译:巨细胞病毒在急性髓样白血病细胞系中诱导HLA-II类限制的同种异体反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cytomegalovirus (HCMV) reactivation is found frequently after allogeneic hematopoietic stem cell transplantation (alloSCT) and is associated with an increased treatment-related mortality. Recent reports suggest a link between HCMV and a reduced risk of cancer progression in patients with acute leukemia or lymphoma after alloSCT. Here we show that HCMV can inhibit the proliferation of the acute myeloid leukemia cell line Kasumi-1 and the promyeloid leukemia cell line NB4. HCMV induced a significant up-regulation of HLA-class-II-molecules, especially HLA-DR expression and an increase of apoptosis, granzyme B, perforin and IFN-γ secretion in Kasumi-1 cells cocultured with peripheral blood mononuclear cells (PBMCs). Indolamin-2,3-dioxygenase on the other hand led only to a significant dose-dependent effect on IFN-γ secretion without effects on proliferation. The addition of CpG-rich oligonucleotides and ganciclovir reversed those antiproliferative effects. We conclude that HCMV can enhance alloreactivity of PBMCs against Kasumi-1 and NB4 cells in vitro. To determine if this phenomenon may be clinically relevant further investigations will be required.
机译:同种异体造血干细胞移植(alloSCT)后经常发现巨细胞病毒(HCMV)的重新激活,并与治疗相关的死亡率增加有关。最近的报道表明,在alloSCT后,急性白血病或淋巴瘤患者HCMV与癌症进展风险降低之间存在联系。在这里,我们显示HCMV可以抑制急性髓样白血病细胞Kasumi-1和早髓样白血病细胞NB4的增殖。 HCMV诱导了HLA-II类分子的显着上调,尤其是HLA-DR表达以及与外周血单核细胞(PBMC)共培养的Kasumi-1细胞的凋亡,颗粒酶B,穿孔素和IFN-γ分泌增加。 。另一方面,Indolamin-2,3-dioxygenase仅对IFN-γ分泌产生显着的剂量依赖性作用,而对增殖没有影响。添加富含CpG的寡核苷酸和更昔洛韦逆转了这些抗增殖作用。我们得出结论,HCMV可以增强PBMC在体外对Kasumi-1和NB4细胞的同种异体反应。为了确定该现象是否可能与临床相关,需要进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号